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Toll-like receptor (TLR)-dependent pathways control
the production of IFNab, a key cytokine in innate
immune control of viruses includingmouse cytomeg-
alovirus (MCMV). The lymphotoxin (LT) ab-LTb re-
ceptor signaling pathway is also critical for defense
against MCMV and thought to aid in the IFNb re-
sponse. We find that upon MCMV infection, mice de-
ficient for lymphotoxin (LT)ab signaling cannotmount
the initial part of a biphasic IFNab response, but show
normal levels of IFNab during the sustained phase of
infection. Significantly, the LTab-dependent, IFNab
response is independent of TLR signaling. B, but
not T, cells expressing LTb are essential for promot-
ing the initial IFNab response. LTbR expression is re-
quired strictly in splenic stromal cells for initial IFNab
production to MCMV and is dependent upon the
NF-kB-inducing kinase (NIK). These results reveal
a TLR-independent innate host defense strategy di-
rected by B cells in communication with stromal cells
via the LTab cytokine system.
INTRODUCTION
Type I interferons (IFNab) play a major role in the innate immune
defense against viral pathogens through direct inhibition of viral
replication in infected cells and by regulating the survival and dif-
ferentiation of key innate effector cells, such as NK cells and T and
B cells of the adaptive immune system. IFNab promotes activa-
tion and maturation of antigen presenting dendritic cells (DC),
facilitating the bridge between innate and adaptive immunity
(Hoebe et al., 2004; Kawai and Akira, 2006; Pascual et al.,
2006). IFNabproduction is initiated by recognition of viral compo-
nents through innate sensing receptors including the Toll-like re-
ceptor (TLR) family, as well as RNA helicase and Pyrin-dependent
systems (reviewed in Benedict and Ware, 2005a, 2005b; Kato
et al., 2006; Meylan and Tschopp, 2006; Werts et al., 2006). Al-
though all nucleated cells can produce IFNab in response to virusinfection, plasmacytoid DC (pDC) produce high levels of IFNa in
response to infection with many different viruses, utilizing largely
TLR-dependent pathways (Delale et al., 2005; Liu, 2005; Siegal
et al., 1999).
Mouse cytomegalovirus (MCMV, a b-herpesvirus) has
emerged as an important model revealing host defense strate-
gies controlling pathogen persistence and latency (Mocarski,
2004; Pollock et al., 1997; Reddehase, 2002). Control of MCMV
requires both innate and adaptive host defenses, with IFNab sig-
naling serving as a key component of innate immunity (Orange
and Biron, 1996). MCMV replicates efficiently in most visceral
organs during the first week of infection, with persistent replica-
tion in the salivary gland continuing for 4–8 weeks en route to es-
tablishing lifelong latency (Mocarski and Courcelle, 2001). IFNab
and NK cells largely limit early replication in the spleen of C57BL/6
(B6) mice, whereas T cells are required for eventual control of
acute infection and reactivation from latency. The pDC has
been identified as a major IFNab-producing cell type in the spleen
at times when IFNa levels have been reported to peak in the
serum of B6 mice (36 hr) (Dalod et al., 2003; Dalod et al.,
2002; Krug et al., 2004).
Evidence that pDC-derived IFNab is key for host defense to
MCMV infection in vivo also comes from data indicating that
mice deficient in TLR9 or MyD88 (the downstream adaptor mol-
ecule required for TLR9 signaling) show depressed levels of
serum IFNab at 36 hr postinfection, and these mice are more
susceptible to MCMV infection (Delale et al., 2005; Krug et al.,
2004). TLR3 signals through the adaptor molecule TRIF, and
TRIF/ mice show increased MCMV replication, although the
TLR3-TRIF pathway appears less important than TLR9 (Hoebe
et al., 2003; Tabeta et al., 2004).
The lymphotoxin (LT)ab-LTb receptor signaling pathway
(Schneider et al., 2004; Ware, 2005) is critical for effective host
defense against MCMV (Banks et al., 2005; Benedict et al.,
2001). Mice deficient in genes encoding LTa, LTb, and LTbR
exhibit increased viral replication in the spleen and liver and in-
creased morbidity, whereas mice deficient in LIGHT, a second li-
gand for the LTbR, show a modest increase in MCMV replication.
The LTbR signaling pathway is thought to aid in promoting an ef-
fective IFNb response, which is linked to survival of cells of the
adaptive immune system. LTa/ mice exhibited a severe defectCell Host & Microbe 3, 67–76, February 2008 ª2008 Elsevier Inc. 67
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LTbR signaling also displayed a profound increase in the apopto-
sis of both T- and B-lymphocytes 3 to 4 days after infection with
MCMV, although these cells were not directly infected. IFNab
receptor deficient mice shared this lymphocyte apoptosis phe-
notype in response to MCMV infection implicating an important
connection between the LT and IFN pathways that allows the
adaptive immune system to survive MCMV infection (Banks
et al., 2005). The LTbR pathway is critically important for the
formation and homeostasis of microenvironments in lymphoid
organs that promote the efficiency of the adaptive immune
Figure 1. Analysis of the IFNab Response during
MCMV Infection
B6 mice were infected with MCMV (2 3 105 PFU i.p.), organs
or serum were harvested at the indicated times for analysis.
(A) The mRNA levels in the spleen for IFNb, IFNa, and MCMV
ie1, ie3, and gB was determined by quantitative RT-PCR
(qPCR) analysis of total cell RNA. All qPCR values are shown
normalized to the levels of 18S rRNA. The baseline mRNA level
in mock-infected B6 mice for IFNb was 2 3 103/18S 3 106
and IFNa 3 3 104/18S 3 106.
(B) Liver mRNA from infected B6 mice as in (A).
(C) Serum IFNa levels were determined by ELISA (ND, not de-
tectable). Each time point represents 3 to 6 mice per group,
mean ± SEM.
responses (Ehlers et al., 2003; Kabashima et al.,
2005). Recent findings suggest that MCMV’s strat-
egy of immune evasion involves targeting an LTbR-
dependent homeostatic pathway. LTbR signaling
regulates stromal cell expression of homeostatic
chemokines, such as CCL21 and CXCL13, required
for trafficking and positioning of T and B cells to their
respective niches in the spleen (Cyster, 2005). Inter-
estingly, MCMV infection selectively downregulates
expression of CCL21, altering T cell positioning in
the splenic white pulp (Benedict et al., 2006).
The role of the LTbR pathway in regulating the in-
nate IFNab response presented a conundrum in
view of evidence indicating that TLR-dependent
pathways are important in both controlling IFNab
production and for resistance to MCMV. Here, we
identify a TLR-independent pathway controlling
the initial IFNab response to MCMV in the spleen.
This pathway involves B lymphocytes expressing
LTab that crosstalk with LTbR-expressing stromal
cells. MCMV preferentially infects the stromal cells
in the spleen, which produce the majority of the ini-
tial IFNab. The results reveal an unorthodox strategy
of the naive adaptive immune system controlling the
innate host IFNab response to a viral pathogen.
RESULTS
The Type I IFN Response to MCMV
in B6 Mice Is Biphasic
Infection of B6 mice with MCMV induced a biphasic
IFNb and IFNa response in the spleen as detected
by quantitative PCR (Figure 1A). The initial splenic IFNb and
IFNa mRNA induced by infection reached maximal accumula-
tion by 8 hours postinfection and then declined over the next
16 hr (Figure 1A). At the peak response, the relative induction
of mRNA was 104-fold increased for IFNb and 105-fold for
IFNa over baseline expression in naive mice. A second, more
sustained accumulation of IFNb and IFNa mRNA occurred
between 36–72 hr. The IFNb mRNA levels that accumulated
in the initial phase was substantially greater than achieved in
the sustained phase (587 mRNA relative units/day versus 17
mRNA units/day) indicating the initial phase accounts for the
68 Cell Host & Microbe 3, 67–76, February 2008 ª2008 Elsevier Inc.
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conditions.
ExpressionofMCMVtranscripts for immediate early (ie)-1and 3,
and the envelope glycoprotein B (gB, an early/late gene product)
were readily detected in the spleen4–8 hrpostinfection (Figure1A).
The levels of ie1 mRNA decreased over the next 16 hr (100-fold),
paralleling the expression profile of IFNa and IFNb mRNA. In con-
trast, ie3 and gB mRNA remained relatively constant over the first
24 hr (Figure 1A). As the infection progressed, viral gene expres-
sion dramatically increased, reaching maximum abundance after
two days, corresponding closely to the peak production of infec-
tious virus,which occurs in the spleens ofB6mice3 to4 dayspost-
infection (Scalzo et al., 1990). This biphasic pattern of viral ie3 and
gB mRNA expression in the spleen suggests that the initial repli-
cation cycle of MCMV was probably completed by 30–36 hr
postinoculation (consistent with the replication cycle in cultured
fibroblasts), followed by spread and additional rounds of virus rep-
lication over the next 2–4 days. The initial IFNab response in the
Figure 2. LTb/LIGHT/ Mice Are Defective in Their
Initial IFNab Response to MCMV
Wild-type (B6) and LTb/LIGHT/-deficient mice were in-
fected with MCMV plus or minus treatment with an agonistic
anti-LTbR antibody (±aLTbR) at the time of infection. Spleens
were harvested 8 hr postinfection and (A) IFNb and ie1 mRNA
levels were determined by qPCR. Serum IFNa levels mea-
sured by ELISA (n = 4–6 mice per group from two independent
experiments, mean ± SEM) (bottom panel). (B) Spleens and
livers from MCMV infected B6 and LTb/LIGHT/ mice were
analyzed by qPCR 8 hr postinfection for IFNb and IE1 mRNA
levels (top two panels). The ratio of IFNb to ie1 mRNA
(3100) is shown (bottom panel, n = 3 mice per group, mean
± SEM). (C) Spleens from B6 and LTb/LIGHT/ mice were
harvested 48 hr postinfection with MCMV, and IFNb and ie1
mRNA levels were determined by qPCR (n = 3 mice per group
± SEM). Mice were injected with 23 105 PFU of MCMV i.p. for
all experiments. Statistical significance (*p < 0.05) was deter-
mined using the Student’s t test, and fold differences are
shown in parentheses.
spleen was proportional to the pfu in the inoculum
of MCMV, as revealed by the identical ratio of
IFNabmRNA to ie1 mRNA at different doses of virus
(Figure S1).
The liver, also a major site of MCMV replication,
showed a similar biphasic IFNab response, al-
though ie1 mRNA levels remained relatively con-
stant over the first 24 hr and increased dramatically
from 2 to 4 days postinfection (Figure 1B). In com-
parison to the spleen, the accumulation of IFNb
mRNA was100-fold lower at the initial times of in-
fection (Figure 1B). Serum levels of IFNa also
showed a biphasic response with maximum serum
levels occurring by 8–12 hr and a second peak at 48
hr concurrent with the first round of virus spread
within organs. Serum IFNawas not detected during
peak virus production over the 72–96 hr period
(Figure 1C). BALB/c mice also displayed a biphasic
IFNab mRNA response to MCMV infection (Fig-
ure S2). These data suggest that the bulk of IFNab
transcriptional activity and serum IFNab response to MCMV
infection occur during the initial phase.
The LTab-LTbR System Is Required for Initial IFNab
Response to MCMV Infection in the Spleen
Although LTa/ mice exhibit a defect in the induction of IFNb
mRNA in the spleen at 8 hr postinfection (Banks et al., 2005), it
was not clear whether LTbR signaling was needed for both
phases of the IFNab response in B6 mice. Mice deficient in
both ligands for LTbR, LTb, and LIGHT (LTb/LIGHT/) were
used to attenuate physiological signaling while retaining the op-
tion to activate LTbR signaling using a specific agonist antibody.
LTb/LIGHT/ mice exhibited reduced IFNb mRNA levels in the
spleen at 8 hr postinfection, consistent with results previously
observed in LTa/ mice (Banks et al., 2005) (Figure 2A). Nota-
bly, a minor decrease in ie1 mRNA expression at this time was
also observed in LTb/LIGHT/ mice (2-fold) (Figure 2B), and
an analogous decrease in ie1 mRNA levels was also seen in
Cell Host & Microbe 3, 67–76, February 2008 ª2008 Elsevier Inc. 69
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and ie1 mRNA in LTb/LIGHT/ mice was comparable to wild-
type B6 mice, indicating that LTbR signaling was dispensable
in the liver (Figure 2B). Moreover, splenic IFNb and ie1 mRNA
levels measured 48 hr after infection in LTb/LIGHT/ mice
were not significantly different from B6 mice (Figure 2C). These
results indicate that LTbR-dependent signaling is required for
the initial IFNab response in the spleen. Serum levels of IFNa
were also dramatically reduced (50-fold) in the LTb/LIGHT/-
deficient mice 8 hr postinfection (Figure 2A) even though IFNab
mRNA levels were not compromised in the liver. This result impli-
cates the spleen as the major source of IFNab during the initial
response to MCMV infection.
Administration of an agonistic anti-LTbR antibody to the LTb/
LIGHT/ mice at the time of MCMV infection partially restored
IFNb mRNA and serum IFNa (Figure 2A). These results indicated
that the LTab/LIGHT-LTbR pathway regulates the initial IFNab
response to MCMV in the spleen, but not in the liver. Further-
more, the ability of an agonist anti-LTbR mAb to partially restore
the splenic IFNb response suggests that signaling through the
LTbR is required during the infection to promote an optimal
IFNab response.
The Initial IFNabResponse toMCMV Is TLR Independent
Toll-like receptor (TLR) sensing of pathogens plays a key role in
innate immune defenses. Importantly, mice deficient in both
TLR9 and TLR3 signaling display increased susceptibility to
MCMV infection with reduced serum levels of IFNab during the
sustained phase (Krug et al., 2004; Tabeta et al., 2004). TLR9Cpg1
mice, which are unresponsive to unmethylated CpG-oligodeox-
ynucleotides (Tabeta et al., 2004), showed normal IFNab mRNA
accumulation in the spleen 8 hr post-MCMV infection. Addition-
ally, TLR9Cpg1 had near normal levels of serum IFNa (Figure 3A)
and IFNb (data not shown) after initial infection. MCMV infection
Figure 3. The Initial Splenic IFNabResponse toMCMV
Infection is TLR Independent
(A) TLR9CpG1, (B) TRIFLps2/Lps2, and (C) MyD88/TRIFLps2/Lps2
were infected with MCMV (2 3 105 PFU i.p.), and the IFNab,
IE1, and ratio of IFNb/IE1 (3100) mRNA levels were deter-
mined by qPCR at 8 hr postinfection in the spleen; serum
IFNa levels were determined by ELISA. Statistical significance
(*p < 0.05) was determined using the Student’s t test, and fold
differences are shown in parentheses. n = 3–6 mice per group
± SEM.
of TRIFLps2/Lps2-deficient mice, which cannot acti-
vate the TLR3 pathway (Hoebe et al., 2003; Yama-
moto et al., 2003), resulted in a slightly higher
induction of IFNb mRNA in the spleen and in
serum IFNa 8 hr postinfection (Figure 3B). IFNa
mRNA levels paralleled serum protein levels for
both TLR9Cpg1- and TRIFLps2/Lps2-deficient mice
(data not shown). To determine whether other
TLRs might function redundantly in TLR9Cpg1 or
TRIFLps2/Lps2 mice, mice deficient in both MyD88
and TRIF signaling pathways were infected (Fig-
ure 3C). These mice showed no decrease in either
IFNb or IFNa mRNA levels, and ie1 levels were also
normal 8 hr postinfection. Taken together, these results indicate
that the LTbR-dependent, initial IFNab response to MCMV in the
spleen is independent of TLR signaling and suggests a specific
LTab-expressing cell population promotes the initial IFNab
response.
The Adaptive Immune System Promotes
the Initial IFNab Response to MCMV
The initial IFNab response to MCMV is rapid, suggesting that
either constitutive or quickly activated LTbR signaling may be re-
quired for promoting this response. A variety of cell types includ-
ing activated T cells, B-lymphocytes, and NK cells express LTb
as well as DC and lymphoid tissue inducer (LTi) cells. However,
naive B cells and CD4+ T cells in the spleen constitutively ex-
press LTb on their cell surface, as detected by flow cytometry
(Figure 4A). To determine the cellular source of LTb, we analyzed
MCMV in RAG/ (which lack T- and B cells) and RAG/gc/
mice (which, in addition, lack NK and LTi cells, due to the ab-
sence of the common g chain of the IL-2/4/7/9/15/21 receptors).
Additionally, splenic DC subpopulations in RAG/ mice are nor-
mal, while DC in RAG/gc/ mice are skewed, with less CD4+
DC (C.D.T., unpublished data). However, both RAG/ and
RAG/gc/ mice showed a substantial reduction in the accumu-
lation of IFNb mRNA compared to wild-type mice (Figure 4B).
Splenic ie1 mRNA levels in both RAG/ and RAG/gc/ mice
at eight hr postinfection trended lower but were not statistically
different from wild-type (Figure 4B). However, normalization of
IFNb to ie1 mRNA revealed a defective initial IFNb mRNA re-
sponse (6-fold) in RAG/ and RAG/gc/ mice, very similar
in magnitude to LTb/LIGHT/ mice. Mice deficient in both
RAG and LTbR were severely compromised in their initial IFNab
response (>50-fold), which was commensurate with a substantial
reduction in ie1 mRNA levels (6-fold). However, the IFNb/ie1
mRNA ratio revealed a comparable, viral ‘‘dose-dependent’’
70 Cell Host & Microbe 3, 67–76, February 2008 ª2008 Elsevier Inc.
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mice (Figure 4B). Serum IFNa levels in RAG/, RAG/gc/,
and RAG/LTbR/ mice during the initial response to MCMV
were undetectable by the ELISA (Figure 4B).
B Cells Expressing LTb Are Required for the Initial
IFNab Response to MCMV
The results observed in RAG/ mice raised the possibility that
naive T and/or B cells provide the stimulus for the initial IFNab re-
sponse to MCMV infection, either directly or indirectly. As both T
and B lymphocytes lack expression of LTbR, it is likely that lym-
phocytes deliver the ligand to LTbR-expressing cells. To delin-
eate which of these lymphocyte populations were the responsi-
ble subset, mice genetically deficient in either B cells (Igh-6/),
CD4+ (Cd4/), or CD8+ T lymphocytes (b2m/) were infected
with MCMV. B cell-deficient mice showed a 4-fold reduction in
Figure 4. The Initial Splenic IFNab Expression during MCMV
Infection Is Dependent upon B-Lymphocytes
(A) Flow cytometric analysis of LTb expression by lymphocytes from B6
and LTb/ spleens. Anti-CD4, CD8, and B220 mAb were used to identify
B and T lymphocyte subsets. Filled histograms represent staining with iso-
type control mAb in B6 mice (B) B6, RAG/ (lack B and T cells), RAG/gc/
(deficient in T, B, and NK cells), and LTbR/RAG double-deficient mice
and (C) B6-, B cell (B/)-, CD4+ T cell (CD4+/)-, and CD8+ T cell
(CD8+/)-deficient mice were infected with MCMV (2 3 105 PFU i.p.).
Spleens were harvested 8 hr postinfection and IFNb and ie1 mRNA levels
were determined by qPCR and normalized to the levels of 18S rRNA (top
two panels of both [B] and [C]). IFNb/ie1 mRNA ratio (3100) was calcu-
lated and serum IFNa levels were determined by ELISA; ND, not detect-
able) (two lower panels). Statistical significance (*p < 0.05) was deter-
mined using the Student’s t test, and fold differences are shown in
parentheses. n = 4–6 mice per group ± SEM.
IFNbmRNA at 8 hr post-MCMV infection and a drastic reduc-
tion in serum IFNa (Figure 4C). In contrast, neither CD4 T cell
nor CD8 T cell-deficient mice showed a reduction in splenic
IFNb mRNA or serum IFNa (Figure 4C). The expression level
of ie1 mRNA was similar in all groups tested.
To directly test whether the lack of LTb expression by B
cells was responsible for the compromised initial IFNab
response to MCMV, mice conditionally deficient in ltb in B-
or (B-LTb) or T cells (T-LTb) were utilized (Tumanov et al.,
2003). Strikingly, B-LTb mice, but not T-LTb mice, displayed
a dramatic reduction in IFNb (7-fold) and IFNa mRNA (12-
fold) (Figure 5). B-LTb-deficient mice also showed3-fold re-
duction in ie1 mRNA in the spleen that when normalized to
ie1 mRNA yielded an 5-fold decrease in IFNab mRNA, a re-
sult virtually identical to that seen in mice lacking the entire B
lymphocyte compartment or deficient in LTb/LIGHT. Taken
together, this result highlights the critical importance of LTb
expressed in B cells to promote the initial IFNab response
to MCMV infection.
LTbR-Expressing Stromal Cells Produce the
Initial IFNab during MCMV Infection via
a NIK-Dependent Pathway
The identification of B-lymphocytes as the critical, LTb-
expressing cells promoting the initial IFNab response to
MCMV in the spleen was surprising given that naive B cells
are not infected by MCMV (Banks et al., 2005) and lack expres-
sion of the LTbR (Force et al., 1996). To determine whether the
hematopoietic or radio-resistant stromal compartments require
expression of the LTbR, bone marrow chimeric mice were gen-
erated between LTbR/ or wild-type mice. LTbR/ recipients
reconstituted with wild-type B6 bone marrow (B6/LTbR) ex-
hibited reduced IFNb mRNA accumulation (10-fold) when
compared to wild-type controls (B6/B6) at 8 hr postinfection
(Figure 6A). This IFNb deficiency was comparable to that seen
in mice defective for LTbR expression in both cellular compart-
ments (LTbR/LTbR). In contrast, wild-type mice that received
LTbR-deficient bone marrow (LTbR/B6) produced normal
levels of IFNb mRNA. Thus, stromal cells require expression of
LTbR to mount the initial IFNab response to MCMV (Figure 6A).
Separation of the spleen into stroma and hematopoietic frac-
tions revealed that IFNb and IFNa mRNA were 25- to 30-fold
Cell Host & Microbe 3, 67–76, February 2008 ª2008 Elsevier Inc. 71
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with MCMV (Figure 6B). Moreover, viral ie1 mRNA expression
also preferentially localized to the stromal compartment (15-
fold enriched) consistent with previous immunohistochemical
(Benedict et al., 2006) and electron microscopy studies (Mercer
et al., 1988) that stromal cells are the major site of MCMV infection
in the spleen. Together, these results indicate that radioresistant
stromal cells expressing the LTbR are both the target of initial in-
fection and the major producer of IFNab in response to MCMV.
LTbR activation of the NF-kB pathway requires the activity of
the NF-kB-inducing kinase (NIK) (Dejardin et al., 2002; Basak
et al., 2007), and LTbR-mediated, canonical NF-kB signaling is
also dependent upon NIK (Basak et al., 2007). To test whether
NIK is required for the initial IFNab response in the splenic
stroma, aly/aly mice (functional mutation in NIK) (Xiao et al.,
2001) were infected with MCMV. Strikingly, aly/aly mice showed
a reduction in both IFNb and IFNa mRNA at 8 hr postinfection
(26- and 104-fold, respectively), with a commensurate reduc-
tion in ie1 mRNA (11-fold).
Discussion
The type I Interferon response is a key contributor to successful
host defense against viral pathogens, such as MCMV (Banks
et al., 2005; Dalod et al., 2002; Salazar-Mather et al., 2002).
Here, we define the cellular interactions required to initiate the
earliest innate IFNab response to a b-herpesvirus. In response
to MCMV, the LTab-LTbR pathway is required for the induction
of IFNab in the spleen, which constitutes a major source of initial
IFNab production. Our results reveal that B-lymphocytes provide
the source of LTb required to promote the initial innate IFNab re-
sponse in LTbR-expressing stromal cells, and it is cells in the
stromal compartment that are both infected and producers of
IFNab during MCMV infection. Induction of initial IFNab mRNA
and protein regulated by the LTbR pathway is independent of
TLR-signaling pathways, indicating that a significant difference
exists in the molecular mechanisms promoting the initial and
sustained phases of the IFNab response to MCMV infection. To-
gether, the results reveal a frontline innate host defense strategy
directed by B cells of the adaptive immune system communicat-
ing with stromal cells via the LTab-LTbR system.
Figure 5. LTb Expressed by B Cells Is Required for the
Initial IFNab Response to MCMV
B6, B-LTb, and T-LTb (mice lacking LTb specifically in B and T
cells, respectively) were infected with MCMV (2 3 105 PFU i.p.).
Spleens were harvested 8 hr postinfection and the IFNb, IFNa,
and ie1 mRNA levels were detected by qPCR and normalized to
18S rRNA. The ratio of IFNb/ie1 mRNA (3100) is shown. Serum
IFNa levels were determined by ELISA. Statistical significance
(*p < 0.05) was determined using the Student’s t test, and fold
differences are shown in parentheses. n = 4–6 mice per group;
average of two independent experiments ± SEM.
The biphasic pattern of IFNab induction in the spleen
and liver reflects the initial host response to the primary
inoculum, with the subsequent sustained phase result-
ing from the secondary response to viral spread and
continued cycles of replication at later times. The initial
IFNabmRNA response to MCMV peaked at 8 hr, paral-
leled by a rise in serum IFNa, rapidly declined and was followed
by sustained expression for the next few days. The accumulated
peak of IFNb mRNA levels indicated the bulk of the IFNab tran-
scriptional activity occurred during the initial phase of the infec-
tion, and the magnitude of the response in the spleen was sub-
stantially higher than in the liver. In addition, the level of IFNa in
the serum, reflecting accumulation from all tissue sources, was
dramatically reduced in the LTb/LIGHT/-deficient mice, de-
spite an uncompromised IFNab mRNA response in the liver.
This evidence, together with the relative abundance of IFNab
mRNA in the spleen, supports the idea that the LTbR pathway
regulates the major source of type I IFN during MCMV infection.
Our results and those of others indicate that TLR-dependent
defense pathways control IFNab expression in response to
MCMV during the later, sustained phase. Thisconclusion is based
on the uncompromised IFNab response to MCMV during the
initial phase in TLR9CpG, TrifLps2/Lps2, and MyD88/TRIFLps2/Lps2
mice. The complexity of the sustained phase of the IFNab
response is apparent from studies showing TLR, MyD88, and
plasmacytoid DC are important at 36 hr post-MCMV infection
(Andoniou et al., 2005; Delale et al., 2005; Krug et al., 2004;
Tabeta et al., 2004), but additional results indicate their influence
may decline at 44 hr postinfection (Andoniou et al., 2005; Delale
et al., 2005; Krug et al., 2004). These data further support the
idea that the initial IFNab response regulated by the LTbR path-
way is distinct from the TLR-dependent pathways functioning in
plasmacytoid DC. These results indicate the LTab-IFN axis is
an independent mechanism from conventional paradigms in
which myeloid lineage cells largely promote innate defenses to
pathogens. Additionally, that LTb/LIGHT/ mice fail to control
acute MCMV replication in both the spleen and liver at 72 hr post-
infection (Banks et al., 2005) indicates mice lacking LTbR-signal-
ing are compromised in additional aspects of innate defenses to
MCMV infection.
The conditional deletion of ltb in B cells, as well as mice lacking
B lymphocytes (RAG/, Igh-6tm1Cgn), demonstrated B cell ex-
pression of LTb is the key factor for promoting the initial IFNab
response in the spleen. B cell-expressed LTb is required for mat-
uration of the normal splenic architecture (Tumanov et al., 2002,
2003) although B-LTb mice develop a normal complement of
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of LTb in lymphoid tissue inducer cells. However, the splenic ar-
chitecture (marginal zone, segregation of T and B cells) in B-LTb
mice is not as severely disrupted as in mice harboring the null ge-
notype, but the IFNb/ie1 mRNA ratio in the spleens of B-LTb and
LTb/LIGHT/ mice were similar in response to MCMV infection.
Additionally, although dendritic cell subpopulations are altered in
the spleen LTbR/B6 bone marrow chimeric mice (Kabashima
et al., 2005; De Trez et al., 2008), the initial IFNab response to
MCMV was normal in these mice. Finally, although LTb/
LIGHT/mice lack both marginal zone and marginal metallophil-
lic macrophage populations, they mount a normal IFNab re-
sponse to MCMV at 48 hr, and our studies in LTbR/B6 mice
indicate LTbR expression by these macrophages is not required
for the initial response. Together, these results indicate that alter-
ations in myeloid cell subsets or the lymphatic vasculature are not
likely to account for the reduced initial IFNab production in LTb/
LIGHT/ mice. Moreover, the partial restoration of the IFNb
mRNA response in LTb/LIGHT/ mice treated with an agonist
anti-LTbR indicates that LTbR signaling contributes during the
virus infection to induce IFNb. The limited effect of acutely deliv-
Figure 6. LTbR-Expressing Splenic Stromal Cells
Promote IFNab Production during MCMV Infection
via a NIK-Dependent Pathway
(A) Various bone marrow chimeric mice (e.g., irradiated wild-
type mice receiving LTbR/ bone marrow = LTbR/B6)
were infected with MCMV for 8 hr (1 3 105 PFU i.v.). Splenic
IFNb (top panel) and ie1 (middle panel) mRNA expression
was determined by qPCR and normalized to 18S rRNA levels.
The ratio of IFNb/IE1 mRNA (3100) is shown in the bottom
panel. Statistical significance (*p < 0.05) was determined using
the Student’s t test comparing each experimental group with
the B6/B6 control mice, and the fold difference is shown in
parentheses. n = 3–5 mice per group ± SEM.
(B) Stromal cells from MCMV (2 3 105 PFU i.v.) infected
spleens (pooled from 5 infected mice) were separated from
hematopoietic cells (see Experimental Procedures). Total
cell RNA was then isolated from either the stromal or hemato-
poietic cell fractions, and qPCR was performed to determine
IFNb, IFNa, and ie1 mRNA levels. (C) aly/aly mice or wild-
type littermate controls (n = 4) were infected with MCMV,
and spleens were analyzed by qPCR for IFNab and ie1
mRNA levels at 8 hr postinfection. Infection conditions and
data analysis is identical to that in (A).
ered anti-LTbR suggests that differentiative effects
on stromal cells may be necessary (Drayton et al.,
2004) to fully restore the IFNab response. The ago-
nist LTbR antibody may also enhance the regulation
of cellular trafficking across the high endothelial
venules, which is regulated by LTbR signaling, per-
haps increasing the initial dissemination of MCMV
to the spleen from the peritoneal cavity (Browning
et al., 2005; Drayton et al., 2003). Strikingly, the
bone marrow chimeric mice indicated that LTb-
expressing B cells exclusively communicate with,
or regulate the differentiation of, LTbR expressing
stromal cells, which produce the majority (>95%)
of the IFNab and IE1 mRNA following MCMV infec-
tion. Along these lines, a role for constitutively
expressed LTb by B cells in regulating the microarchitecture of
the spleen was recently shown to play an important role in con-
taining VSV and LCMV infection (Junt et al., 2006). LTab is exclu-
sively positioned in the membrane indicating the conversation
between B cells and stromal cells occurs through direct cell con-
tact. The radioresistant stromal compartment includes many
distinct cell types that could be infected, including endothelial
cells, myocytes, and fibroblasts in addition to specialized paren-
chymal cells identified by specific chemokine expression, such
as CXCL13 (Cyster, 2003). The exact lineage of stromal cells
infected by MCMV in the spleen is currently unknown.
The importance of this B cell-stromal cell interaction is evident
in LT deficient mice, which are highly susceptible to infection with
MCMV (for review see Ware, 2005). Increased morbidity occurs in
LTa-, LTb-, or LTbR-deficient mice or wild-type mice treated with
LTbR-Fc decoy in response to MCMV (Banks et al., 2005; Bene-
dict et al., 2001). Mice deficient in IFNab receptor phenocopy
LT-deficient mice, which undergo massive apoptosis of T and
B lymphocytes during infection that are not directly infected by
the virus (Banks et al., 2005). LTbR expression was required in
both the hematopoietic and stromal compartments of the spleen
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implicating crosstalk occurs between the myeloid and stromal
compartments to induce IFNab and promote survival of lympho-
cytes (Banks et al., 2005). Our results in aly/aly mice strongly in-
dicate this LT-dependent crosstalk requires NIK, likely involving
activation of NF-kB, a known key player in the regulation of
IFNb transcription (Thanos and Maniatis, 1995). Together, these
results indicate that the initial B cell directed IFNab response
contributes to viral control, and ultimately helps to promote the
survival of the adaptive immune response.
B lymphocytes play a critical role in the post natal maturation
and homeostasis of the splenic microarchitecture, a structural
feature designed to promote highly efficient immune responses
(Cupedo et al., 2004). LTab-LTbR signaling pathway is required
to form the marginal zone, wherein antigen-capturing macro-
phages, B cells and dendritic cells reside (Kraal, 1992) and reg-
ulate expression of the lymphoid tissue chemokines (CCL21,
CXCL13) in specialized stromal cells creating discrete micro-
niches that compartmentalize T cells to the periarteriole region
surrounded by the B cell follicles (Cyster, 2003). MCMV targets
the splenic microarchitecture by specifically suppressing ex-
pression of CCL21 mRNA, evident two to three days after infec-
tion (Benedict et al., 2006). The specific loss of CCL21 leaves T
cells without sufficient cues to localize around the arteriole. How-
ever, MCMV did not significantly alter the B cell follicle chemo-
kine CXCL13, unlike infection with lymphocytic choriomeningitis
virus, which reduces expression of both these splenic chemo-
kines (Mueller et al., 2007) suggesting the LT-IFN pathway might
protect the B cell micro-niche during MCMV infection.
The commitment of genomic information encoding resistance
to MCMV (estimated at 1%–3% of the host genome) suggests
herpesviruses provide powerful selective pressures for diversifi-
cation of host resistance mechanisms (Beutler et al., 2005). Like-
wise, the accumulation of numerous immune modulating mech-
anisms in the viral genome, many derived from ‘‘captured’’
cellular genes, indicates a long coevolutionary history. That two
distinct human herpesviruses, HSV-1 and HCMV, target recep-
tors (HVEM and BTLA) involved in LT-dependent signaling, un-
derscores this coevolutionary relationship (Cheung et al., 2005).
Indeed, resistance to other pathogens is provided to the host
as a consequence of infection with eitherg- and b-herpesviruses,
suggesting a strong symbiotic relationship has emerged from the
host-virus interplay (Barton et al., 2007). In the context of evolu-
tion, the LTab-LTbR pathway, functioning as a developmental
and homeostatic regulator, may have evolved as an adaptive
countermeasure to promote an early IFN response in the cells ini-
tially infected by the virus, perhaps in response to the functional
paralysis of macrophages and DC by MCMV (Andrews et al.,
2001; Popkin et al., 2003). The discovery of this B cell-dependent
pathway also suggests an unrecognized route to IFNab produc-
tion that may operate in autoimmune diseases, such as lupus
erythematosus, where both infection and genetic factors contrib-
ute to pathogenesis (Baccala et al., 2007).
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6 (B6), B6 CD45.1, BALB/c, 129, C57BL/10, B6.129S2-Igh-
6tm1Cgn/J (B/), B6.129S2-Cd4tm1Mak/J (CD4/), and B6.129P2-
B2mtm1Unc/J (CD8/) were purchased from the Jackson Laboratory, and
RAG2/ RAG2/(gc)/ (C57BL/6J x C57BL/10SgSnAi)-[KO]gc-[KO]RAG2)
double-deficient mice were from Taconic. LTb/LIGHT (Scheu et al., 2002)
and LTbR/ (Futterer et al., 1998) were backcrossed five generations
(n = 5) to B6 mice. LTa/ mice were generated as described (De Togni
et al., 1994) and were obtained from Jackson Labs. LTbR/ mice were
crossed onto RAG1/ (C57BL/6) mice at LIAI. The conditional LTb-deficient
mice were derived by breeding LTb ‘‘floxed’’ mice with CD19-Cre knockin mice
for the B cell-specific deletion, and CD4-Cre transgenic mice were used for T
cell-specific deletion (Tumanov et al., 2003). TLR9CpG1 mice and TrifLps2/Lps2
mice generated on the C57BL/6 background by ENU mutagenesis were ob-
tained from Dr. Bruce Beutler (Hoebe et al., 2003; Tabeta et al., 2004).
MyD88/TRIFLps2/Lps2 doubly deficient mice were obtained from Dr. Sujan
Shresta, (constructed by Dr. S. Akira and Dr. B. Beutler). All mice were
used at 6–12 weeks and were age and sex matched. Mice were treated
with the agonist rat anti-mouse LTbR at 100 mg injected i.p. at the time of
infection.
For bone marrow transplantation, recipient mice were lethally irradiated
(1000 rad) and reconstituted with total donor bone marrow cells (107 cells/
recipient mouse) by injection into the retro-orbital sinus of the recipients; recip-
ient mice were given antibiotics in the drinking water for 3 weeks. The chimeric
mice were analyzed 7 weeks post transfer; recipient mice were analyzed
with CD45 allelic markers (LTbR/ CD45.2 or B6 CD45.1) to verify reconsti-
tution.
Virus
Mouse CMV (Smith strain) was prepared from salivary glands from infected
BALB/c mice as described previously (Benedict et al., 2001). Preparations
were derived from a virus stock acquired from the ATCC (VR-1399) that was
propagated twice through mouse salivary glands for amplification/generation
of a ‘‘seed stock.’’ This seed stock was then used to infect mice to generate
viral stocks for use in all experiments. In addition, all stocks were centrifuged
through a 20% sorbitol cushion and resuspended in PBS. The infectious virus
in the preparation was quantified by plaque assay on NIH 3T3 cells (Redde-
hase et al., 1985). All breeding and experimental protocols were performed
under the approval by LIAI Animal Care Committee.
Quantitative PCR
Gene expression was assayed by quantitative RT-PCR (Stratagene Mx4000),
as described (Benedict et al., 2001). Total cellular RNA was isolated from snap
frozen tissues using the TRIzol reagent and purified with RNeasy Mini RNA pu-
rification kit (QIAGEN, Chatsworth, CA). RNA was treated with DNaseI and 2 mg
were used for the RT reaction. The primers for detection of murine IFNb, IFNa
and the MCMV immediate early genes IE1, IE3 and late gene gB were: IFNb,
50-CTGGAGCAGCTGAATGGAAAG-30 and 50-CTCCGTCATCTCCATAGGGAT
CT-30; IFNa, 50-TGCAATGACCTCCATCAGCA-30 and 50-TTCCTGGGTCAGAG
GAGGTTC-30; IE1, 50-AGCTGTTGGTGGTGTCACTCAA-30 and 50-GGCTGGG
ACTCATCTTCTTCAG-30 IE3 50-AGCTGTTGGTGGTGTCACTCAA-30 and GGC
TGGGACTCATCTTCTTCAG-30, gB, 50-GGGCGAGAACAACGAGATCA-30 and
50-TCTTCCTGCTGTTCGTGTCG-30. All mRNA levels were normalized to 18S
rRNA in individual samples, except in one case where L32 was used. IFNa
primers were designed to hybridize to a region of the IFNa mRNA that is
100% conserved in 13/14 murine IFNa subtypes. Real-time PCR data was
analyzed using the Relative Expression Software Tool (REST) for groupwise
comparison and statistical analysis of relative gene expression (Pfaffl et al.,
2002) and with Prism Software (Student’s pairwise t test).
Interferon ELISA
IFNa and IFNb serum levels were quantified using ELISA that detects mouse
IFN-aA, a1, a4, a5, a6, and a9. Briefly, plates coated with a rat anti-mouse
IFNa mAb (RMMA-1, PBL Biomedical Laboratories) were incubated with se-
rum samples, followed by rabbit anti-mouse IFNa polyclonal Ab (PBL Biomed-
ical Laboratories), and horseradish peroxidase-conjugated goat anti-rabbit
IgG for detection (Jackson ImmunoReaserch Laboratories) with the substrate
TMB (eBioscience). Recombinant IFNa (PBL Biomedical Laboratories) was
used to generate a standard curve (12.5-500pg/ml). Colorimetric changes of
enzyme substrates were detected at 450 nm (SpectraMax, Molecular Devices)
and data analyzed with the SOFTmax Pro software.
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Spleens from mice infected for 8 hours with 23 105 PFU of MCMV were sep-
arated into a stroma and hematopoietic fractions, RNA extracted for Real Time
PCR analysis as previously described (Benedict et al., 2006). Briefly, spleens
were perfused with collagenase (100 U/ml) in Hanks’ Balanced Salt Solution
containing Ca2+ and Mg2 for 30 min at 37C. Treated spleens from five mice
were then pooled and extruded through a 70 mm nylon filter strainer in order
to obtain sufficient amounts of stromal cell RNA. Cells extruded through the fil-
ter (hematopoietic fraction) and cells retained on filter (stromal fraction) were
washed with PBS followed by lysis with Trizol. The filter-bound stromal fraction
from uninfected mice contained a maximum of 15%–30% contaminating he-
matopoietic cells, and 4%–7% contaminating stromal cells in the hematopoi-
etic fraction based on marker genes expressed exclusively in the hematopoi-
etic (CD80, IL-7Ra, LTa, and LTb) and stromal (gp38 and IL-7) compartments.
Flow Cytometry
Single cell suspensions of splenic leukocytes were preincubated with anti-
FcgRII/III blocking reagent (2.4G2; BD PharMingen). Cell surface LTb was de-
tected with monoclonal antibody BB.F6.F6.BF2 (BD PharMingen) followed by
biotinylated goat anti-hamster IgG and Streptavidin APC. For the lymphocyte
subset detection the following antibodies from BD were used: PE 145-2C11
(anti-CD3), FITC RM4-4 (anti-CD4), FITC 53-6.7 (anti-CD8), and PE RA3-6B2
(anti-B220). Stained cells were analyzed on a FACSCalibur flow cytometer
using CellQuest research software (BD Biosciences) and FlowJo Software.
Supplemental Data
The Supplemental Data include three supplemental figures and can be found
with this article online at http://www.cellhostandmicrobe.com/cgi/content/full/
3/2/67/DC1/.
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